These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 34566995)

  • 1. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation.
    El Baba R; Herbein G
    Front Immunol; 2021; 12():730765. PubMed ID: 34566995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity.
    Yuan Q; Fan Z; Huang W; Huo X; Yang X; Ran Y; Chen J; Li H
    mBio; 2024 Jul; 15(7):e0119124. PubMed ID: 38829126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
    Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subversion of Immune Response by Human Cytomegalovirus.
    Patro ARK
    Front Immunol; 2019; 10():1155. PubMed ID: 31244824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
    Front Immunol; 2021; 12():532484. PubMed ID: 33897679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
    Amsler L; Verweij M; DeFilippis VR
    J Mol Biol; 2013 Dec; 425(24):4857-71. PubMed ID: 24013068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
    Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
    J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
    Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
    Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The battle between host antiviral innate immunity and immune evasion by cytomegalovirus.
    Li S; Xie Y; Yu C; Zheng C; Xu Z
    Cell Mol Life Sci; 2024 Aug; 81(1):341. PubMed ID: 39120730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.
    Sabbaghian M; Gheitasi H; Fadaee M; Javadi Henafard H; Tavakoli A; Shekarchi AA; Poortahmasebi V
    Arch Virol; 2024 Jul; 169(8):157. PubMed ID: 38969819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus induces and exploits Roquin to counteract the IRF1-mediated antiviral state.
    Song J; Lee S; Cho DY; Lee S; Kim H; Yu N; Lee S; Ahn K
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18619-18628. PubMed ID: 31451648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors and Cytomegalovirus: An Intimate Interplay.
    Herbein G
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse immune evasion strategies by human cytomegalovirus.
    Noriega V; Redmann V; Gardner T; Tortorella D
    Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV immune evasion and manipulation of the immune system with aging.
    Jackson SE; Redeker A; Arens R; van Baarle D; van den Berg SPH; Benedict CA; Čičin-Šain L; Hill AB; Wills MR
    Geroscience; 2017 Jun; 39(3):273-291. PubMed ID: 28647908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prominent Role of the Human Cytomegalovirus UL8 Glycoprotein in Restraining Proinflammatory Cytokine Production by Myeloid Cells at Late Times during Infection.
    Pérez-Carmona N; Martínez-Vicente P; Farré D; Gabaev I; Messerle M; Engel P; Angulo A
    J Virol; 2018 May; 92(9):. PubMed ID: 29467314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay between Human Cytomegalovirus and Pathogen Recognition Receptor Signaling.
    Marques M; Ferreira AR; Ribeiro D
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30241345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus immunity and immune evasion.
    Jackson SE; Mason GM; Wills MR
    Virus Res; 2011 May; 157(2):151-60. PubMed ID: 21056604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.